18 news items
AbbVie Recommends Shareholders Reject Tutanota's "Mini-Tender" Offer
ABBV
14 Jun 24
requests that a copy of this news release be included with all distribution of materials related to Tutanota's offer for shares of AbbVie common
AbbVie Announces Positive Topline Results from Phase 2 PICCOLO Trial Evaluating Mirvetuximab Soravtansine (ELAHERE®) for High Folate Receptor-Alpha (FRα) Expressing Platinum-Sensitive Ovarian Cancer
ABBV
6 Jun 24
cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties include
SkinMedica® Celebrates 25 Years of Empowering Radiant Skin
ABBV
6 Jun 24
to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements
AbbVie Launches First-of-its-Kind Contest to Empower People Living with Migraine in their Careers
ABBV
6 Jun 24
cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those
AbbVie Advances Oncology Pipeline With Start of Multiple Myeloma Phase 3 Clinical Trial for Investigational Asset ABBV-383
ABBV
5 Jun 24
and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks
scmjd4l4xqaffampu7dvikvqsz126y0xo4ci2phsylbffc2w
ABBV
4 Jun 24
that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed
h3ms4jaqhpcv7f2wzck0wt8dl44yj1b1yfnnscu5n1
ABBV
31 May 24
are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements
usm6x55ehub sww1gw0mokqgtw2wvsd2tbzc4
ABBV
CYTO
ONCY
24 May 24
are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER
vtptij8fhnrev1568xfvh8h27x42u1crqa1xx4co5afpb
ABBV
LABP
23 May 24
actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties include
aa7444ebdfy39i5m6bpr692kibnq11rvf43if33nywm
ABBV
17 May 24
actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties include
oc1ja6k
ABBV
13 May 24
that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed
aaz6w9r
AAL
AAPL
ABBV
29 Apr 24
. On the other hand, healthcare, energy, and materials have reported year-over-year earnings declines.
See Also
sgcq8svcsauqmu9c9dwaq21q5p1ri3vgttmdodqn6z0lr550
ABBV
25 Apr 24
that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties
31cgc41p5axbimk5heqzuz1loju9p4db uouuumwk2qc3fvyp07w944grov
ABBV
18 Apr 24
cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those
icryoqwe6q9a42uvqjh3jvyjvyv9c4ctnup
ABBV
12 Apr 24
that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties include
k8ao4x2b4rp0315jhnbv25 5le36wx
ABBV
25 Mar 24
are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking
sbhu3aeprq47yh55vt8bz5kkg6votdgse1gkh 7q70
ABBV
LABP
25 Mar 24
cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties include: (i
l8v8suvzgjcpql9uheei2t3fzairm7 fi0lbbc1yk2asvmb8
ABBV
22 Mar 24
and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks
- Prev
- 1
- Next